Kynurenic acid inhibits colon cancer proliferation in vitro: Effects on signaling pathways

Amino Acids

Volumn 46, Issue 10, 2014, Pages 2393-2401

  Walczak, Katarzyna ^a   Turski, Waldemar A ^a   Rajtar, Grazyna ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Colon cancer; Kynurenic acid; MAPK; PI3K Akt pathway; Signaling pathways; Wnt pathway

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CATENIN; CTNNB1 PROTEIN, HUMAN; KYNURENIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; TUMOR PROTEIN;

ADENOCARCINOMA; AGONISTS; CELL PROLIFERATION; CHEMISTRY; COLONIC NEOPLASMS; DOWN REGULATION; DRUG EFFECTS; DRUG POTENTIATION; GENE EXPRESSION REGULATION; GENETICS; HT 29 CELL LINE; HUMAN; METABOLISM; OSMOLARITY; PATHOLOGY; PHOSPHORYLATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; UPREGULATION; WNT SIGNALING PATHWAY;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; BETA CATENIN; CELL PROLIFERATION; COLONIC NEOPLASMS; DOWN-REGULATION; DRUG SYNERGISM; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMANS; KYNURENIC ACID; MAP KINASE SIGNALING SYSTEM; NEOPLASM PROTEINS; OSMOLAR CONCENTRATION; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; UP-REGULATION; WNT SIGNALING PATHWAY;

EID: 84930741113     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-014-1790-3     Document Type: Article

References (42)

1. Baran H, Staniek K, Kepplinger B, Gille L, Stolze K, Nohl H (2001) Kynurenic acid influences the respiratory parameters of rat heart mitochondria. Pharmacology 62:119-123
2. Burgering BM, Coffer PJ (1995) Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376:599-602
3. Chang L, Karin M (2001) Mammalian MAP kinase signalling cascades. Nature 410:37-40
4. DiNatale BC, Murray IA, Schroeder JC, Flaveny CA, Lahoti TS, Laurenzana EM, Omiecinski CJ, Perdew GH (2010) Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling. Toxicol Sci 115:89-97
5. Duronio V (2008) The life of a cell: apoptosis regulation by the PI3K/PKB pathway. Biochem J 415:333-344
6. Efferth T (2012) Signal transduction pathways of the epidermal growth factor receptor in colorectal cancer and their inhibition by small molecules. Curr Med Chem 33:5735-5744
7. Franke TF, Kaplan DR, Cantley LC (1997) PI3K: downstream AKTion blocks apoptosis. Cell 88:435-437
8. Fre S, Pallavi SK, Huyghe M, Laé M, Janssen KP, Robine S, Artavanis-Tsakonas S, Louvard D (2009) Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine. Proc Natl Acad Sci USA 106:6309-6314
9. Fujii-Kuriyama Y, Kawajiri K (2010) Molecular mechanisms of the physiological functions of the aryl hydrocarbon (dioxin) receptor, a multifunctional regulator that senses and responds to environmental stimuli. Proc Jpn Acad Ser B Phys Biol Sci 86:40-53
10. Gesbert F, Sellers WR, Signoretti S, Loda M, Griffin JD (2000) BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway. J Biol Chem 275:39223-39230
11. Hajduch E, Litherland GJ, Hundal HS (2001) Protein kinase B (PKB/Akt) - a key regulator of glucose transport? FEBS Lett 492:199-203
12. Halilovic E, Solit DB (2008) Therapeutic strategies for inhibiting oncogenic BRAF signaling. Curr Opin Pharmacol 8:419-426
13. Holloway G, Coulson BS (2006) Rotavirus activates JNK and p38 signaling pathways in intestinal cells, leading to AP-1-driven transcriptional responses and enhanced virus replication. J Virol 80:10624-10633
14. Inoki K, Li Y, Zhu T, Wu J, Guan KL (2002) TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 4:648-657
15. Kuc D, Rahnama M, Tomaszewski T, Rzeski W, Wejksza K, Urbanik-Sypniewska T, Parada-Turska J, Wielosz M, Turski WA (2006) Kynurenic acid in human saliva - does it influence oral microflora? Pharmacol Rep 58:393-398
16. Kuc D, Zgrajka W, Parada-Turska J, Urbanik-Sypniewska T, Turski WA (2008) Micromolar concentration of kynurenic acid in rat small intestine. Amino Acids 35:503-505
17. Kyriakis JM, Avruch J (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81:807-869
18. Liu P, Cheng H, Roberts TM, Zhao JJ (2009) Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov 8:627-644
19. Loesch M, Zhi HY, Hou SW, Qi XM, Li RS, Basir Z, Iftner T, Cuenda A, Chen G (2010) p38gamma MAPK cooperates with c-Jun in trans-activating matrix metalloproteinase 9. J Biol Chem 285:15149-15158
20. Luksch H, Uckermann O, Stepulak A, Hendruschk S, Marzahn J, Bastian S, Staufner C, Temme A, Ikonomidou C (2011) Silencing of selected glutamate receptor subunits modulates cancer growth. Anticancer Res 31:3181-3192
21. Maaetoft-Udsen K, Shimoda LM, Frøkiær H, Turner H (2012) Aryl hydrocarbon receptor ligand effects in RBL2H3 cells. J Immunotoxicol 9:327-337
22. Manning BD, Cantley LC (2007) AKT/PKB signaling: navigating downstream. Cell 129:1261-1274
23. Marciniak A, Turski WA (2010) A novel medical use of kynurenic acid, its precursors and derivatives. International Patent WO20101 10689, 23 March 2010
24. Paluszkiewicz P, Zgrajka W, Saran T, Schabowski J, Piedra JL, Fedkiv O, Rengman S, Pierzynowski SG, Turski WA (2009) High concentration of kynurenic acid in bile and pancreatic juice. Amino Acids 37:637-641
25. Pasz-Walczak G, Jesionek-Kupnicka D, Kubiak R, Kordek R (2004) Podstawowe mechanizmy kancerogenezy w jelicie grubym. Współcz Onkol 8:303-307
26. Rubinfeld H, Seger R (2005) The ERK cascade: a prototype of MAPK signaling. Mol Biotechnol 31:151-174
27. Rzeski W, Turski L, Ikonomidou C (2001) Glutamate antagonists limit tumour growth. Proc Natl Acad Sci USA 98:6372-6377
28. Saal LH, Johansson P, Holm K, Gruvberger-Saal SK, She QB, Maurer M, Koujak S, Ferrando AA, Malmström P, Memeo L, Isola J, Bendahl PO, Rosen N, Hibshoosh H, Ringnér M, Borg A, Parsons R (2007) Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity. Proc Natl Acad Sci USA 104:7564-7569
29. Stepulak A, Sifringer M, Rzeski W, Endesfelder S, Gratopp A, Pohl EE, Bittigau P, Felderhoff-Mueser U, Kaindl AM, Bührer C, Hansen HH, Stryjecka-Zimmer M, Turski L, Ikonomidou C (2005) NMDA antagonist inhibits the extracellular signal-regulated kinase pathway and suppresses cancer growth. Proc Natl Acad Sci USA 102:15605-15610
30. Sundqvist A, Bengoechea-Alonso MT, Ye X, Lukiyanchuk V, Jin J, Harper JW, Ericsson J (2005) Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCFFbw7. Cell Metab 1:379-391
31. Turski MP, Turska M, Zgrajka W, Kuc D, Turski WA (2009) Presence of kynurenic acid in food and honeybee products. Amino Acids 36:75-80
32. Turski MP, Turska M, Zgrajka W, Bartnik M, Kocki T, Turski WA (2011) Distribution, synthesis, and absorption of kynurenic acid in plants. Planta Med 77:858-864
33. Walczak K, Dąbrowski W, Langner E, Zgrajka W, Piłat J, Kocki T, Rzeski W, Turski WA (2011) Kynurenic acid synthesis and kynurenine aminotransferases expression in colon derived normal and cancer cells. Scand J Gastroenterol 46:903-912
34. Walczak K, Turski WA, Rzeski W (2012a) Kynurenic acid enhances expression of p21 Waf1/Cip1 in colon cancer HT-29 cells. Pharmacol Rep 64:745-750
35. Walczak K, Zurawska M, Kis̈ J, Starownik R, Zgrajka W, Bar K, Turski WA, Rzeski W (2012b) Kynurenic acid in human renal cell carcinoma: its antiproliferative and antimigrative action on Caki-2 cells. Amino Acids 43:1663-1670
36. Walczak K, Deneka-Hannemann S, Jarosz B, Zgrajka W, Stoma F, Trojanowski T, Turski WA, Rzeski W (2014) Kynurenic acid inhibits proliferation and migration of human glioblastoma T98G cells. Pharmacol Rep 66:130-136
37. Wang J, Simonavicius N, Wu X, Swaminath G, Reagan J, Tian H, Ling L (2006) Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J Biol Chem 281:22021-22028
38. Wei W, Jin J, Schlisio S, Harper JW, Kaelin WG Jr (2005) The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase. Cancer Cell 8:25-33
39. Welcker M, Singer J, Loeb KR, Grim J, Bloecher A, Gurien-West M, Clurman BE, Roberts JM (2003) Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation. Mol Cell 12:381-392
40. Yeh E, Cunningham M, Arnold H, Chasse D, Monteith T, Ivaldi G, Hahn WC, Stukenberg PT, Shenolikar S, Uchida T, Counter CM, Nevins JR, Means AR, Sears R (2004) A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol 6:308-318
41. Zarubin T, Han J (2005) Activation and signaling of the p38 MAP kinase pathway. Cell Res 15:11-18
42. Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC (2001) Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol 3:245-252